Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
China
· Delayed Price · Currency is CNY 7.08
+0.16 (2.31%)
Apr 30, 2026, 3:00 PM CST
SHA:600351 Market Cap
SHA:600351 has a market cap or net worth of 4.79 billion as of April 29, 2026. Its market cap has increased by 8.59% in one year.
Market Cap
4.79B
Enterprise Value
3.90B
Revenue
2.20B
Ranking
n/a
PE Ratio
15.08
Stock Price
7.08
Market Cap Chart
Since September 26, 2002, SHA:600351's market cap has increased from 2.68B to 4.79B, an increase of 78.52%. That is a compound annual growth rate of 2.49%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wuhan Hiteck Biological Pharma Co.,Ltd | 4.69B |
| Hunan Fangsheng Pharmaceutical | 4.74B |
| Bide Pharmatech | 4.78B |
| Tibet Weixinkang Medicine | 4.59B |
| Hubei Biocause Heilen Pharmaceutical | 4.84B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 4.54B |
| Shandong Sinobioway Biomedicine | 4.53B |
| Newland Pharmaceutical | 4.53B |